231 related articles for article (PubMed ID: 17087289)
1. [Glucose intolerance: postprandial hyper glucose, risk factor for diabetic macroangiopathy].
Igarashi Y; Kawamori R
Nihon Rinsho; 2006 Nov; 64(11):1998-2004. PubMed ID: 17087289
[TBL] [Abstract][Full Text] [Related]
2. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
Madsbad S; Brock B; Schmitz O
Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
4. Post-prandial hyperglycemia and microvascular complications.
Dhanwal D; Tandon N
J Assoc Physicians India; 2001 Jan; 49 Spec No():28-31. PubMed ID: 11235602
[No Abstract] [Full Text] [Related]
5. [Glinide(s), sulfonylurea(s)].
Arakawa M; Hirose T
Nihon Rinsho; 2006 Nov; 64(11):2107-12. PubMed ID: 17087304
[TBL] [Abstract][Full Text] [Related]
6. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
7. Role of postprandial hyperglycemia in cardiovascular disease.
Fava S
Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
[TBL] [Abstract][Full Text] [Related]
8. [Postprandial hyperglycemia and diabetic complications].
Da Ros R; Assaloni R; Ceriello A
Recenti Prog Med; 2005 Sep; 96(9):436-44. PubMed ID: 16229326
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of blood glucose levels in the pathogenesis of (atherosclerotic) macroangiopathy].
Simon K
Orv Hetil; 2004 Apr; 145(16):861-6. PubMed ID: 15156691
[TBL] [Abstract][Full Text] [Related]
10. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
Sjöholm A
Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of macroangiopathy in diabetes, including international comparisons].
Nishimura R
Nihon Rinsho; 2006 Nov; 64(11):2012-8. PubMed ID: 17087291
[TBL] [Abstract][Full Text] [Related]
12. Post-prandial hyperglycaemia and vascular disease.
Hanefeld M
Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946
[No Abstract] [Full Text] [Related]
13. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
Sakamoto N; Tajima N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
[No Abstract] [Full Text] [Related]
14. [Pathophysiological conditions progressing from impaired glucose tolerance: coronary artery disease (ischemic heart disease)].
Tomono S; Uchiyama T; Ohyama Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():255-9. PubMed ID: 15779382
[No Abstract] [Full Text] [Related]
15. [Management of blood glucose--target of the management and its practice].
Ishibashi S
Nihon Rinsho; 2006 Nov; 64(11):2089-94. PubMed ID: 17087301
[TBL] [Abstract][Full Text] [Related]
16. [Early diagnosis of peripheral neuropathy in patients with impaired glucose tolerance (IGT)].
Yagihashi S
Nihon Rinsho; 2005 Jun; 63 Suppl 6():640-6. PubMed ID: 15999784
[No Abstract] [Full Text] [Related]
17. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
Zeymer U
Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
[TBL] [Abstract][Full Text] [Related]
19. [Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy].
Igarashi M; Tominaga M
Nihon Rinsho; 2005 Feb; 63 Suppl 2():55-60. PubMed ID: 15779345
[No Abstract] [Full Text] [Related]
20. Mechanisms of tissue damage in the postprandial state.
Ceriello A
Int J Clin Pract Suppl; 2001 Sep; (123):7-12. PubMed ID: 11594300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
